Fetal retinoid syndrome (FRS) is a congenital disorder observed in fetuses exposed to retinoids, such as isotretinoin, during pregnancy. This syndrome is characterized by multiple anomalies, including microcephaly, cardiac malformations, limb anomalies, and facial skeletal abnormalities. It is important to note that the severity and spectrum of anomalies may vary depending on the timing and duration of exposure to the teratogen. FRS is a serious complication affecting the quality of life of newborns and requires a comprehensive approach to diagnosis and treatment.
History of the disease and interesting historical facts
Fetal retinoid syndrome was first described in 1982, when a group of researchers from the United States recorded a link between the use of isotretinoin and various malformations. The relevance of the problem increased after it was soon established that even small doses of retinoids can have a negative effect on the fetus. An important aspect is that retinoids are used not only to treat acne, but also in oncology, skin beautification and other dermatological diseases. Thus, high doses of retinoids can significantly increase the likelihood of developing FRS, which strongly emphasizes the need for in-depth research into their effect on pregnancy.
Epidemiology
According to various studies, the incidence of fetal retinoid syndrome ranges from 0.5 to 1 case per 10,000 live births. One study published in the Journal of Teratology indicates that when isotretinoin is used during the first trimester, the incidence of FRS can reach 25%. This is of particular concern to physicians and consumers, since acne in women of childbearing age is a common problem in some countries, which significantly increases the risk.
Genetic predisposition to this disease
Genetic studies suggest that FRS may be associated with mutations in genes that affect the fetus. Several studies have implicated genes such as RARα, RARβ, and RXRα, which play key roles in cell proliferation and differentiation. Mutations in these genes may disrupt the normal development of organs and tissues in the fetus, leading to phenotypic abnormalities. However, it is important to note that not all children born to mothers who have used retinoids will have FRS, suggesting that there may be additional factors that influence the expression of the disease.
Risk factors for the development of this disease
There are several factors that may increase the risk of developing fetal retinoid syndrome:
- Use of isotretinoin or other retinoids during pregnancy.
- Pregnancy period - the greatest risk is observed in the first trimester.
- The presence of predisposing genetic factors.
- Comorbid conditions such as diabetes or obesity may make the situation worse.
In addition, there are exogenous factors, such as intense exposure to ultraviolet radiation or the use of certain cosmetics, that may also increase the likelihood of abnormalities in the fetus.
Diagnosis of this disease
Diagnosis of fetal retinoid syndrome includes several stages:
- History - examination of the mother's history of retinoid use.
- The main symptoms include malformations of the facial structures, structural abnormalities of the heart, and abnormalities in the structure of the limbs.
- Laboratory tests - may include genetic testing for mutations.
- Radiological examinations - ultrasound helps to identify anatomical abnormalities of the fetus.
- Differential diagnosis - must be carried out with other syndromes, such as Down syndrome or Tarner syndrome.
Treatment
Treatment of FRS depends on the severity of the clinical picture and includes:
- General treatment is supportive therapy to improve functional status.
- Pharmacological treatment may include hormonal drugs to correct various disorders.
- Surgical treatment is necessary in cases of severe developmental defects to correct functional disorders.
- Other types of treatment include working with speech therapists and psychologists to assist with social and psychological adaptation.
List of medications used to treat this disease
There is currently no specific medication to treat FRS. However, supportive care may include:
- Hormonal drugs.
- Medicines for the correction of concomitant diseases.
- Physiotherapy to improve functional status.
Disease monitoring
Monitoring of patients with FRS includes regular medical examinations, specialized tests to assess the functionality of organs and systems. It is also important to monitor the development of psycho-emotional and social skills of patients. The prognosis for children with FRS varies depending on the severity of the anomalies, and in some cases full development is possible. More severe forms can lead to complications that require long-term treatment and close monitoring.
Age-related features of the disease
Fetal retinoid syndrome may manifest itself differently depending on the age group. In newborns, physiological and morphological abnormalities are most pronounced, while in older children, symptoms may include developmental delays and psychoemotional disorders. While isolated abnormalities are sometimes observed in children, a whole complex of sociopathological and adaptation disorders may develop in adolescents and adults.
Questions and Answers
- What are the main symptoms of fetal retinoid syndrome? The main symptoms include malformations of the facial structures, heart defects and limb abnormalities.
- Can FRS be prevented in expectant mothers? Yes, avoiding the use of retinoids during pregnancy significantly reduces the risk of developing FRS.
- How does the FRS diagnostics work? Diagnosis is made based on anamnesis, physical examination and radiological studies.
- What is the outlook for children with FRS? The outlook depends on the severity of the abnormalities and can range from mild discomfort to severe abnormalities.
- When should I see a doctor if I suspect I have FRS? If there is a history of retinoid use during pregnancy and developmental abnormalities in the child are observed, you should immediately contact a specialist.
Dr. Oleg Korzhikov advises paying special attention to preventive measures to prevent fetal retinoid syndrome. “It is important to be careful in choosing medications during pregnancy and always consult a doctor before starting any treatment. If you are planning a pregnancy and have used retinoids, it is necessary to discuss a plan to stop these drugs and other possible alternatives to minimize the risks to the unborn child,” the doctor adds.
